Credit Agricole
UTMD icon

Credit Agricole’s Utah Medical Products UTMD Stock Holding History

Credit Agricole’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-89,681
Closed -$4.05M – 1592
2017
Q1 		$4.05M Buy
+89,681
New +$5.64M 0.01% 800

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Credit Agricole's UTMD Position: Q2 2017 in Review

Credit Agricole sold out of Utah Medical Products (UTMD) in Q2 2017, closing a stake of 89,681 shares — an estimated $4.05M sold.

Credit Agricole first reported a position in UTMD in Q1 2017 and held it in 1 quarter. The position peaked at $4.05M in Q1 2017. 76 funds tracked by Wall St. Rank hold UTMD as of Q2 2017.

  • Credit Agricole reported no remaining Utah Medical Products position as of Q2 2017 after selling out during the quarter.
  • Credit Agricole sold 89,681 Utah Medical Products shares in Q2 2017, an estimated $4.05M.
  • Credit Agricole first reported a position in Utah Medical Products in Q1 2017 and held it in 1 quarter.
  • Credit Agricole's Utah Medical Products position peaked at $4.05M in Q1 2017.
  • 76 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2017.

Based on Credit Agricole's 13F filing for Q2 2017, filed 14 Aug 2017.